zolmitriptaan

Zolmitriptan is a selective serotonin receptor agonist (5-HT1F) used to treat migraines. It is available in oral tablet form and is typically taken when a migraine attack begins. Zolmitriptan works by blocking serotonin receptors in the brain, which helps to reduce the pain and other symptoms associated with migraines. It is often used as an alternative to triptans, another class of drugs used to treat migraines, and is considered to be effective in preventing migraine attacks.

Zolmitriptan is generally well-tolerated, with common side effects including headache, dizziness, and nausea. Serious side effects are rare but can include allergic reactions, stroke, and serotonin syndrome. It is important to consult a healthcare provider before taking zolmitriptan, especially if you have a history of stroke, high blood pressure, or are pregnant or breastfeeding.

Zolmitriptan is available under the brand name Zomig and is manufactured by Allergan. It is not approved for use in children under the age of 18. The typical dosage for adults is 2.5 mg, taken orally, and should be taken as soon as possible after the onset of a migraine attack. It is important to follow the instructions provided by your healthcare provider or on the medication label.